Cura Life

CuraLife mission is to maximize patient health outcomes through nutraceutical offerings and a range of digital therapeutics. CuraLife novel Direct-to-Patient approach is disrupting the healthcare industry with physical therapeutics (effective and safe innovative natural solutions) and digital therapeutics (smart technology to make every day just simple). Through combining clinically positioned dietary supplements, condition-based communities and behavior-changing technology, CuraLife is redefining healthcare. CuraLife develops Curalin to control glucose levels for people suffering from type 2 diabetes. A first clinical trial on 35 patients, published in February 2023, showed 3 times reduction of Hb1AC. A second clinical trial on 85 patients in 4 centers completed in August 2023, proving outstanding results – 13 times reduction of HbA1C in 3 months.